The diagnosis and treatment of thyroid-associated ophthalmopathy

Aesthetic Plast Surg. 2012 Jun;36(3):638-48. doi: 10.1007/s00266-011-9843-4. Epub 2011 Nov 16.

Abstract

Background: Little is written in the plastic surgery literature about thyroid-associated ophthalmopathy (TAO), a condition that is separate from Graves-Basedow disease and may not be accompanied by hyperthyroidism. Many patients with this disease frequently seek periocular aesthetic reconstruction prior to medical workup.

Methods: This study presents a comprehensive review of the literature surrounding TAO in order to better understand the prevalence, diagnosis, pathophysiology, and appropriate management of TAO.

Results: TAO is frequently under- or misdiagnosed by health-care providers. Patients seeking blepharoplasty or other oculoplastic procedures may have underlying TAO, and the prevalence of TAO in patients who have had a blepharoplasty is approximately 3%. This condition occurs five times more often in women than in men. As a product of the relatively high prevalence of this disease and its underdiagnosis, TAO patients may experience perioperative and late complications due to surgery.

Conclusion: Blepharoplasties performed on TAO patients must be undertaken with care and insight to avoid cosmetic and functional complications.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Algorithms
  • Graves Ophthalmopathy / diagnosis*
  • Graves Ophthalmopathy / etiology
  • Graves Ophthalmopathy / therapy*
  • Humans